Mammary Neoplasms, Experimental - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	Mammary Neoplasms, Experimental	go back to main search page
Accession:	RDO:0006058	browse the term
Definition:	Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
Synonyms:	exact_synonym:	Experimental Mammary Neoplasm
	primary_id:	MESH:D008325

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

Mammary Neoplasms, Experimental
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb1a	ATP-binding cassette, sub-family B (MDR/TAP), member 1A			ISS	4	21,709,855	21,796,628	RGD:2315553	RGD
G	Abcb1b	ATP-binding cassette, subfamily B (MDR/TAP), member 1B			ISS	4	21,829,489	21,912,239	RGD:2315553	RGD
G	Agtr1a	angiotensin II receptor, type 1a			IEP	17	40,629,318	40,684,982	RGD:2292665	RGD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1			ISS	6	137,640,482	137,657,552	RGD:2315600	RGD
G	Akt2	v-akt murine thymoma viral oncogene homolog 2			ISS	1	82,686,233	82,726,544	RGD:2315600	RGD
G	Alox5ap	arachidonate 5-lipoxygenase activating protein			IEP	12	6,245,808	6,269,796	RGD:2313895	RGD
G	Anxa1	annexin A1			IEP	1	223,478,436	223,494,455	RGD:2306898	RGD
G	Apaf1	apoptotic peptidase activating factor 1			IED	7	27,932,908	28,020,533	RGD:2325748	RGD
G	Areg	amphiregulin			ISS	14	18,466,313	18,475,571	RGD:2292663	RGD
G	Areg	amphiregulin			IEP	14	18,466,313	18,475,571	RGD:2292665	RGD
G	Atf2	activating transcription factor 2			ISS	3	56,403,676	56,496,473	RGD:704409	RGD
G	Bak1	BCL2-antagonist/killer 1			ISS	20	5,255,954	5,264,593	RGD:2315700	RGD
G	Bard1	BRCA1 associated RING domain 1			ISS	9	70,120,151	70,198,591	RGD:2293149	RGD
G	Brca1	breast cancer 1, early onset			ISS	10	90,513,630	90,572,676	RGD:734655	RGD
G	Brca1	breast cancer 1, early onset			IEP	10	90,513,630	90,572,676	RGD:1599502	RGD
G	Brca1	breast cancer 1, early onset		Susceptibility	ISS	10	90,513,630	90,572,676	RGD:2293149	RGD
G	Brca1	breast cancer 1, early onset			ISS	10	90,513,630	90,572,676	RGD:2293155	RGD
G	Cad	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase		Disease_progression	IEP	6	25,272,416	25,296,266	RGD:2303540	RGD
G	Car9	carbonic anhydrase 9			IEP	5	59,986,413	59,993,015	RGD:2293194	RGD
G	Casp1	caspase 1			IEP	8	2,027,976	2,036,872	RGD:2315886	RGD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase			ISS	5	160,704,234	160,721,796	RGD:2315928	RGD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase			IED	5	160,704,234	160,721,796	RGD:2315933	RGD
G	Cav1	caveolin 1, caveolae protein		Onset	ISS	4	42,956,102	42,989,057	RGD:2289106	RGD
G	Cav1	caveolin 1, caveolae protein			ISS	4	42,956,102	42,989,057	RGD:2289100	RGD
G	Ccna2	cyclin A2			ISS	2	123,062,752	123,069,085	RGD:2293347	RGD
G	Ccnb1	cyclin B1			ISS	2	31,574,600	31,581,784	RGD:2315939	RGD
G	Ccnd1	cyclin D1			IEP	1	205,357,235	205,366,757	RGD:2289336	RGD
G	Ccnd1	cyclin D1			ISS	1	205,357,235	205,366,757	RGD:2296037	RGD
G	Ccnd1	cyclin D1			IEP	1	205,357,235	205,366,757	RGD:2289337	RGD
G	Ccnd3	cyclin D3			IEP				RGD:2316020	RGD
G	Ccnd3	cyclin D3			ISS				RGD:2316015	RGD
G	Ccne1	cyclin E1			IEP	1	90,568,189	90,577,426	RGD:2289336	RGD
G	Ccne1	cyclin E1			IEP	1	90,568,189	90,577,426	RGD:2289337	RGD
G	Ccr3	chemokine (C-C motif) receptor 3			ISS	8	128,759,943	128,769,341	RGD:6893427	RGD
G	Cdc25a	cell division cycle 25A			ISS	8	114,237,704	114,255,971	RGD:2771824	RGD
G	Cdc25a	cell division cycle 25A			ISS	8	114,237,704	114,255,971	RGD:2764000	RGD
G	Cdc25a	cell division cycle 25A			ISS	8	114,237,704	114,255,971	RGD:2754551	RGD
G	Cdh13	cadherin 13			ISS	19	48,507,173	49,575,123	RGD:734735	RGD
G	Cdh13	cadherin 13			ISS	19	48,507,173	49,575,123	RGD:2293540	RGD
G	Cdk2	cyclin dependent kinase 2			ISS	7	2,000,196	2,007,682	RGD:2293558	RGD
G	Cdk4	cyclin-dependent kinase 4			IEP				RGD:2293581	RGD
G	Cdk4	cyclin-dependent kinase 4		Susceptibility	ISS				RGD:2293577	RGD
G	Cdkn1b	cyclin-dependent kinase inhibitor 1B			IEP	4	171,841,705	171,846,506	RGD:2293626	RGD
G	Cdkn1b	cyclin-dependent kinase inhibitor 1B			ISS	4	171,841,705	171,846,506	RGD:734746	RGD
G	Cdkn2a	cyclin-dependent kinase inhibitor 2A		Disease_progression	ISS	5	108,908,749	108,916,380	RGD:2289674	RGD
G	Cdkn2a_v1	cyclin-dependent kinase inhibitor 2A, variant 1		Disease_progression	ISS				RGD:2289674	RGD
G	Cdkn2a_v2	cyclin-dependent kinase inhibitor 2A, variant 2		Disease_progression	ISS				RGD:2289674	RGD
G	Cds1	CDP-diacylglycerol synthase 1			ISS	14	9,074,826	9,135,391	RGD:734755	RGD
G	Col18a1	collagen, type XVIII, alpha 1		Severity	IED	20	11,920,816	11,982,468	RGD:70690	RGD
G	Csf1	colony stimulating factor 1 (macrophage)			ISS	2	203,292,765	203,307,968	RGD:2293710	RGD
G	Ctnnb1	catenin (cadherin associated protein), beta 1			ISS	8	125,978,161	125,987,670	RGD:2289674	RGD
G	Ctnnb1	catenin (cadherin associated protein), beta 1			ISS	8	125,978,161	125,987,670	RGD:2289816	RGD
G	Dio1	deiodinase, iodothyronine, type I			IED	5	128,385,702	128,404,015	RGD:727335	RGD
G	Egfr	epidermal growth factor receptor			ISS	14	97,617,358	97,788,211	RGD:2289979	RGD
G	Erbb2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)			IED	10	87,219,157	87,242,919	RGD:2289920	RGD
G	Erbb2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)			ISS	10	87,219,157	87,242,919	RGD:2289979	RGD
G	Erbb3	v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)			ISS	7	1,858,057	1,877,353	RGD:2289979	RGD
G	Erbb4	v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)			ISS	9	66,843,898	67,967,970	RGD:2289979	RGD
G	Esr1	estrogen receptor 1		Susceptibility	ISS	1	35,523,680	35,759,891	RGD:2290019	RGD
G	Fas	Fas (TNF receptor superfamily, member 6)			ISS	1	238,259,443	238,274,745	RGD:2290047	RGD
G	Fbxo10	F-box protein 10			IEP	5	61,601,192	61,626,997	RGD:1601189	RGD
G	Fgf10	fibroblast growth factor 10			IEP	2	50,866,799	50,940,319	RGD:2292665	RGD
G	Fgf7	fibroblast growth factor 7			ISS	3	113,468,427	113,517,538	RGD:2301094	RGD
G	Fgf8	fibroblast growth factor 8			ISS	1	250,951,023	250,956,730	RGD:2301098	RGD
G	Flt3	fms-related tyrosine kinase 3			ISS	12	8,193,629	8,268,682	RGD:2302211	RGD
G	Frmpd1	FERM and PDZ domain containing 1			IEP	5	61,748,052	61,849,848	RGD:1601189	RGD
G	Gh1	growth hormone 1			IPM	10	95,692,240	95,694,117	RGD:2315650	RGD
G	Gsn	gelsolin			IEP	3	14,360,245	14,386,313	RGD:1599869	RGD
G	H19	H19, imprinted maternally expressed transcript (non-protein coding)			IEP	1	202,822,925	202,825,601	RGD:1642758	RGD
G	Hras	Harvey rat sarcoma virus oncogene			IAGP	1	201,385,705	201,388,987	RGD:2314834	RGD
G	Il18bp	interleukin 18 binding protein			IEP	1	159,471,809	159,473,288	RGD:2313895	RGD
G	Ilk	integrin-linked kinase			ISS	1	163,481,299	163,487,550	RGD:2301733	RGD
G	Kdr	kinase insert domain receptor			IED				RGD:2291936	RGD
G	Kdr	kinase insert domain receptor			ISS				RGD:5684399	RGD
G	Kit	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog			IAGP	14	34,906,043	34,984,819	RGD:2302172	RGD
G	Krt7	keratin 7			IEP	7	140,160,829	140,226,474	RGD:2317439	RGD
G	Lhcgr	luteinizing hormone/choriogonadotropin receptor			IPM	6	12,613,622	12,651,587	RGD:2302177	RGD
G	Lnpep	leucyl/cystinyl aminopeptidase			IEP	1	56,063,361	56,151,257	RGD:1582109	RGD
G	Mmp13	matrix metallopeptidase 13		Severity	ISS	8	4,158,887	4,169,166	RGD:2306081	RGD
G	Mmp15	matrix metallopeptidase 15			ISS	19	10,122,553	10,143,853	RGD:2314949	RGD
G	Mmp2	matrix metallopeptidase 2			IEP	19	15,246,036	15,275,061	RGD:2325823	RGD
G	Mmp9	matrix metallopeptidase 9			IEP	3	155,985,473	155,993,433	RGD:2325823	RGD
G	Notch4	notch 4			ISS	20	4,263,205	4,287,312	RGD:2299154	RGD
G	Phb	prohibitin			IEP				RGD:2292404	RGD
G	Plau	plasminogen activator, urokinase		Disease_progression	IPM	15	3,680,072	3,686,232	RGD:6484140	RGD
G	Pten	phosphatase and tensin homolog		Onset	ISS	1	236,771,027	236,837,261	RGD:2292496	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			IPM	13	64,427,288	64,432,978	RGD:2300130	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			IEP	13	64,427,288	64,432,978	RGD:5135030	RGD
G	Ptgs2	prostaglandin-endoperoxide synthase 2			ISS	13	64,427,288	64,432,978	RGD:2300118	RGD
G	Ptk2	protein tyrosine kinase 2		Disease_progression	ISS	7	110,933,298	111,084,554	RGD:2292554	RGD
G	Ptk2	protein tyrosine kinase 2			IPM	7	110,933,298	111,084,554	RGD:2292560	RGD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)			ISS	1	208,262,669	208,273,148	RGD:2298764	RGD
G	Rnpep	arginyl aminopeptidase (aminopeptidase B)			IEP	13	48,267,923	48,286,295	RGD:1582109	RGD
G	Rxra	retinoid X receptor alpha			IPM	3	6,605,782	6,689,224	RGD:1643109	RGD
G	Socs1	suppressor of cytokine signaling 1			ISS	10	4,819,971	4,820,609	RGD:2298899	RGD
G	Socs3	suppressor of cytokine signaling 3			ISS	10	107,958,468	107,959,330	RGD:2298899	RGD
G	Stat1	signal transducer and activator of transcription 1			ISS	9	46,455,635	46,497,560	RGD:2291895	RGD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)			ISS	10	89,821,078	89,872,970	RGD:2291914	RGD
G	Stat5a	signal transducer and activator of transcription 5A			IEP	10	89,795,404	89,819,732	RGD:2291927	RGD
G	Stat5a	signal transducer and activator of transcription 5A		Susceptibility	ISS	10	89,795,404	89,819,732	RGD:2298539	RGD
G	Stat5a	signal transducer and activator of transcription 5A			IEP	10	89,795,404	89,819,732	RGD:2291932	RGD
G	Stat6	signal transducer and activator of transcription 6, interleukin-4 induced			ISS	7	67,623,534	67,642,283	RGD:2298563	RGD
G	Stc2	stanniocalcin 2			IEP	10	16,514,603	16,524,369	RGD:2313895	RGD
G	Tdg	thymine-DNA glycosylase			ISS	7	23,300,450	23,320,095	RGD:2317355	RGD
G	Terc	telomerase RNA component			ISS	2	117,234,446	117,234,833	RGD:2291975	RGD
G	Thbs1	thrombospondin 1			IEP				RGD:1626167	RGD
G	Tnfrsf10b	tumor necrosis factor receptor superfamily, member 10b			ISS	15	50,138,439	50,163,254	RGD:2290495	RGD
G	Tp53	tumor protein p53		Disease_progression	ISS	10	56,399,721	56,411,150	RGD:2290539	RGD
G	Tp53	tumor protein p53			IEP	10	56,399,721	56,411,150	RGD:2290577	RGD
G	Txnip	thioredoxin interacting protein		Severity	IEP	2	191,356,954	191,360,757	RGD:1642758	RGD
G	Tyms	thymidylate synthetase			IPM	9	112,604,912	112,617,706	RGD:2315839	RGD
G	Ube2i	ubiquitin-conjugating enzyme E2I			ISS	10	14,509,948	14,524,551	RGD:2301345	RGD
G	Wnt1	wingless-type MMTV integration site family, member 1			ISS	7	137,557,836	137,561,883	RGD:2298863	RGD
G	Wnt1	wingless-type MMTV integration site family, member 1			ISS	7	137,557,836	137,561,883	RGD:2298848	RGD
G	Wnt2	wingless-type MMTV integration site family member 2			ISS	4	43,649,783	43,689,596	RGD:2298863	RGD
G	Wnt2	wingless-type MMTV integration site family member 2			ISS	4	43,649,783	43,689,596	RGD:2298848	RGD
G	Wnt3	wingless-type MMTV integration site family, member 3			ISS	10	92,925,605	92,969,613	RGD:2298848	RGD
G	Wnt3a	wingless-type MMTV integration site family, member 3A			ISS	10	45,553,682	45,594,983	RGD:2298848	RGD
G	Wnt3a	wingless-type MMTV integration site family, member 3A			ISS	10	45,553,682	45,594,983	RGD:2298863	RGD
G	Wnt5b	wingless-type MMTV integration site family, member 5B			ISS	4	155,747,648	155,763,554	RGD:2298863	RGD
G	Wnt5b	wingless-type MMTV integration site family, member 5B		No_Association	ISS	4	155,747,648	155,763,554	RGD:2298848	RGD
G	Wnt6	wingless-type MMTV integration site family, member 6		No_Association	ISS	9	74,104,364	74,117,995	RGD:2298863	RGD
G	Wnt6	wingless-type MMTV integration site family, member 6			ISS	9	74,104,364	74,117,995	RGD:2298848	RGD
G	Wnt7a	wingless-type MMTV integration site family, member 7A			ISS	4	125,541,281	125,586,167	RGD:2298848	RGD
G	Wnt7a	wingless-type MMTV integration site family, member 7A			ISS	4	125,541,281	125,586,167	RGD:2298863	RGD
G	Wnt7b	wingless-type MMTV integration site family, member 7B		No_Association	ISS	7	123,533,713	123,554,333	RGD:2298848	RGD
G	Wnt7b	wingless-type MMTV integration site family, member 7B			ISS	7	123,533,713	123,554,333	RGD:2298863	RGD
Q	Emca1	Estrogen-induced mammary cancer QTL 1			IED	5	103,677,659	155,120,876	RGD:1358124	RGD
Q	Emca10	Estrogen-induced mammary cancer QTL 10		Induced	IAGP	6	1,301,952	46,301,952	RGD:2292503	RGD
Q	Emca2	Estrogen-induced mammary cancer QTL 2			IED	18	18,562,790	66,652,461	RGD:1358124	RGD
Q	Emca4	Estrogen-induced mammary cancer QTL 4			IED	7	66,201,980	107,428,439	RGD:1642522	RGD
Q	Emca5	Estrogen-induced mammary cancer QTL 5			IED	3	41,054,012	171,063,335	RGD:1642522	RGD
Q	Emca6	Estrogen-induced mammary cancer QTL 6			IED	4	41,729,583	159,115,617	RGD:1642522	RGD
Q	Emca7	Estrogen-induced mammary cancer QTL 7			IED	6	2,802,670	111,967,837	RGD:1642522	RGD
Q	Emca8	Estrogen-induced mammary cancer QTL 8			IED	5	52,434,178	148,460,381	RGD:1642522	RGD
Q	Mamtr1	Mammary tumor resistance QTL 1			IED	5	12,880,403	119,333,229	RGD:631852	RGD
Q	Mamtr1	Mammary tumor resistance QTL 1			IAGP	5	12,880,403	119,333,229	RGD:631852	RGD
Q	Mamtr5	Mammary tumor resistance QTL 5			IED	5	19,206,257	64,206,257	RGD:1599390	RGD
Q	Mamtr6	Mammary tumor resistance QTL 6			IED	18	19,892,650	86,863,412	RGD:1599390	RGD
Q	Mamtr7	Mammary tumor resistance QTL 7		Induced	IED	10	9,762,188	108,776,963	RGD:2302423	RGD
Q	Mamtr8	Mammary tumor resistance QTL 8		Induced	IED	18	32,458,819	86,863,412	RGD:2302423	RGD
Q	Mcs1	Mammary carcinoma susceptibility QTL 1			IED	2	5,601,528	22,318,848	RGD:61080	RGD
Q	Mcs12	Mammary carcinoma susceptibility QTL 12			IED	5	61,238,737	62,299,211	RGD:6893465	RGD
Q	Mcs13	Mammary carcinoma susceptibility QTL 13			IED	5	65,553,185	73,080,336	RGD:1559294	RGD
Q	Mcs14	Mammary carcinoma susceptibility QTL 14			IED	5	79,919,505	84,434,576	RGD:1559294	RGD
Q	Mcs15	Mammary carcinoma susceptibility QTL 15			IED	10	89,575,059	108,822,775	RGD:1581951	RGD
Q	Mcs16	Mammary carcinoma susceptibility QTL 16			IED	1	2,436,832	37,799,020	RGD:1599317	RGD
Q	Mcs17	Mammary carcinoma susceptibility QTL 17			IED	1	202,763,018	247,763,018	RGD:1599317	RGD
Q	Mcs18	Mammary carcinoma susceptibility QTL 18			IED	2	5,601,528	35,247,994	RGD:1599317	RGD
Q	Mcs19	Mammary carcinoma susceptibility QTL 19			IED	5	103,956,411	108,590,465	RGD:1599317	RGD
Q	Mcs2	Mammary carcinoma susceptibility QTL 2			IED	7	21,161,002	38,377,911	RGD:61081	RGD
Q	Mcs20	Mammary carcinoma susceptibility QTL 20			IED	9	8,991,206	39,691,794	RGD:1599317	RGD
Q	Mcs21	Mammary carcinoma susceptibility QTL 21			IED	10	29,541,648	54,220,239	RGD:1599317	RGD
Q	Mcs22	Mammary carcinoma susceptibility QTL 22			IED	18	54,856,551	67,024,547	RGD:1599317	RGD
Q	Mcs23	Mammary carcinoma susceptibility QTL 23			IAGP				RGD:1601189	RGD
Q	Mcs24	Mammary carcinoma susceptibility QTL 24			IAGP	5	70,181,758	115,181,758	RGD:1601189	RGD
Q	Mcs25	Mammary carcinoma susceptibility QTL 25		Induced	IED	6	7,161,389	115,238,799	RGD:4143380	RGD
Q	Mcs26	Mammary carcinoma susceptibility QTL 26		Induced	IED	6	111,239,053	138,260,635	RGD:4143380	RGD
Q	Mcs27	Mammary carcinoma susceptibility QTL 27		Induced	IED	13	44,872,181	49,428,577	RGD:4143380	RGD
Q	Mcs28	Mammary carcinoma susceptibility QTL 28			IAGP				RGD:5684388	RGD
Q	Mcs29	Mammary carcinoma susceptibility QTL 29			IAGP				RGD:5684388	RGD
Q	Mcs3	Mammary carcinoma susceptibility QTL 3			IED	1	102,532,145	134,980,682	RGD:61081	RGD
Q	Mcs4	Mammary carcinoma susceptibility QTL 4			IED	8	61,443,447	64,762,616	RGD:61081	RGD
Q	Mcs5	Mammary carcinoma susceptibility QTL 5			IED	5	58,063,971	139,156,771	RGD:62417	RGD
Q	Mcs6	Mammary carcinoma susceptibility QTL 6			IED	7	29,204,226	68,057,251	RGD:62417	RGD
Q	Mcs7	Mammary carcinoma susceptibility QTL 7			IED	10	76,698,917	121,698,917	RGD:62417	RGD
Q	Mcs8	Mammary carcinoma susceptibility QTL 8			IED	14	4,895,894	26,416,791	RGD:62417	RGD
Q	Mcsm1	Mammary carcinoma susceptibility modifier QTL 1			IED	6	61,787,263	106,787,263	RGD:62417	RGD
S	ACI.COP-(D10Mgh8-D10Rat4)/Shul			Induced	IAGP	10	53,781,126	107,033,716	RGD:2292503	RGD
S	ACI.COP-(D3Mgh16-D3Rat119)/Shul			Induced	IAGP	3	6,373,335	52,643,538	RGD:2292503	RGD
S	ACI.COP-(D3Rat130-D3Rat114)/Shul			Induced	IAGP	3	44,551,252	149,496,698	RGD:2292503	RGD
S	ACI.COP-(D6Rat80-D6Rat146)/Shul			Induced	IAGP	6	16,302,145	16,302,283	RGD:2292503	RGD
S	ACI/N	A X C 9935, Irish			TAS				RGD:1004	RGD
S	ACI/SegHsd			Model	IED				RGD:1358124	RGD
S	BN/NHsdMcwi			Resistance	IED				RGD:2301186	RGD
S	BUF/N				TAS				RGD:1004	RGD
S	DON	Donryu rat			TAS				RGD:1004	RGD
S	LEW	Lewis			TAS				RGD:1004	RGD
S	NSD/N				TAS				RGD:1004	RGD
S	OM	Osborne-Mendel			TAS				RGD:1004	RGD
S	SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm			Induced	IED	10	9,762,188	108,776,963	RGD:2302423	RGD
S	SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm				IED	18	19,892,650	86,863,412	RGD:2302423	RGD
S	SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm			Induced	IED				RGD:2302423	RGD
S	SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm				IED	5	24,978,084	24,978,263	RGD:2302423	RGD
S	SPRD/Hsd			Susceptibility	TAS				RGD:2291885	RGD
S	SS-Chr 10^BN/Mcwi			Susceptibility	IED				RGD:2301186	RGD
S	SS-Chr 12^BN/Mcwi			Susceptibility	IED				RGD:2301186	RGD
S	SS.BN-(D13Rat111-D13Got22)/Mcwi			Induced	IED	13	32,030,139	42,627,837	RGD:4143380	RGD
S	SS.BN-(D13Rat123-D13Rat101)/Mcwi			Induced	IED	13	44,872,181	49,428,577	RGD:4143380	RGD
S	SS.BN-(D13Rat151-D13Rat197)/Mcwi			Induced	IED	13	80,109,432	100,133,413	RGD:4143380	RGD
S	SS.BN-(D13Rat7-D13Rat60)/Mcwi			Induced	IED	13	1,084,268	13,053,933	RGD:4143380	RGD
S	SS.BN-(D6Rat119-D6Arb3)/Mcwi			Induced	IED	6	111,239,053	138,260,635	RGD:4143380	RGD
S	SS.BN-(D6Rat149-D6Arb3)/Mcwi			Induced	IED	6	7,161,389	138,260,635	RGD:4143380	RGD
S	SS.BN-(D6Rat149-D6Got171)/Mcwi			Induced	IED	6	7,161,389	123,782,965	RGD:4143380	RGD
S	SS.BN-(D6Rat149-D6Rat18)/Mcwi			Induced	IED	6	7,161,389	93,374,504	RGD:4143380	RGD
S	SS/JrHsdMcwi			Susceptibility	IED				RGD:2301186	RGD
S	WF	Wistar Furth			TAS				RGD:1004	RGD
S	WF.COP-(D7Rat39-D7Uwm12)/1Uwm				IED	7	4,936,703	86,007,499	RGD:5133689	RGD
S	WF.COP-(D7Rat39-D7Uwm12)/2Uwm				IED	7	4,936,703	86,007,499	RGD:5133689	RGD
S	WF.WKY-(D5Uwm67-D5Uwm78)/Uwm				IED	5	79,919,505	79,919,776	RGD:5684388	RGD
S	WF.WKY-(D5Uwm67-D5Uwm81)/Uwm				IED	5	79,919,505	79,919,776	RGD:5684388	RGD
S	WF.WKY-(D5Uwm67-D5Uwm98)/Uwm				IED	5	79,919,505	79,919,776	RGD:5684388	RGD
S	WF.WKY-(D5Uwm68-D5Mit4)/Uwm				IED	5	77,277,626	94,516,069	RGD:5684388	RGD
S	WF.WKY-(D5Uwm76-D5Got18)/Uwm				IED	5	82,406,661	82,406,827	RGD:5684388	RGD
S	WF.WKY-(D5Uwm76-D5Uwm61)/Uwm				IED	5	84,434,303	84,434,576	RGD:5684388	RGD
S	WF.WKY-(D5Uwm76-D5Uwm92)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm76-D5Uwm98)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm77-D5Uwm91)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm78-D5Uwm84)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm78-D5Uwm93)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm78-D5Uwm98)/Uwm				IED	5	82,406,661	82,406,827	RGD:5684388	RGD
S	WF.WKY-(D5Uwm82-D5Uwm91)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm82-D5Uwm92)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm85-D5Uwm92)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm87-D5Uwm92)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm88-D5Uwm92)/Uwm				IED				RGD:5684388	RGD
S	WF.WKY-(D5Uwm95-D5Uwm98)/Uwm				IED	5	82,406,661	82,406,827	RGD:5684388	RGD
S	WF.WKY-(D7Rat171-D7Rat128)/1Uwm			Resistance	IED	7	22,382,724	121,524,220	RGD:5133689	RGD
S	WF.WKY-(D7Rat171-D7Rat128)/2Uwm			Resistance	IED	7	22,382,724	121,524,220	RGD:5133689	RGD
S	WF.WKY-(D7Rat171-D7Rat45)/Uwm				IED	7	22,382,724	68,057,251	RGD:5133689	RGD
S	WF.WKY-(D7Rat51-D7Rat128)/Uwm			Resistance	IED	7	50,833,677	121,524,220	RGD:5133689	RGD
S	WF.WKY-(D7Uwm25-D7Rat128)/Uwm				IED	7	121,523,977	121,524,220	RGD:5133689	RGD
S	WF/NHsd			Susceptibility	TAS				RGD:2291885	RGD

Term paths to the root

Path 1
Term	Annotations
Diseases	30466
Neoplasms	5206
Neoplasms, Experimental	305
Mammary Neoplasms, Experimental	223
Path 2
Term	Annotations
Diseases	30466
Neoplasms	5206
Neoplasms by Site	3793
Mammary Neoplasms, Animal	241
Mammary Neoplasms, Experimental	223